Innoviva
INVA
98 hedge funds and large institutions have $993M invested in Innoviva in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 35 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
37% more capital invested
Capital invested by funds: $724M → $993M (+$269M)
15% more call options, than puts
Call options by funds: $1.04M | Put options by funds: $908K
10% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 31
18% less funds holding
Funds holding: 119 → 98 (-21)
60% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$21.3M |
| 2 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
+$7.33M |
| 3 |
AAM
Advisors Asset Management
Monument,
Colorado
|
+$4.91M |
| 4 |
CC
Clearline Capital
New York
|
+$4.08M |
| 5 |
GL
GLG LLC
New York
|
+$3.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Perry Capital
New York
|
-$18M |
| 2 |
First Eagle Investment Management
New York
|
-$12.9M |
| 3 |
State Street
Boston,
Massachusetts
|
-$10M |
| 4 |
O
OppenheimerFunds
New York
|
-$6.5M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$5.75M |
INVA Hedge Fund Activity: Q4 2015 in Review
98 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q4 2015, worth a combined $993M — up 37% from $724M a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of INVA and 14 opened new positions — a net loss of 21 holders — while 31 trimmed existing stakes and 34 added.
The largest buyer was PFM Health Sciences, opening a new position worth an estimated $21.3M. The largest seller was Perry Capital, exiting entirely with an estimated $18M sold.
- 98 institutional investors held Innoviva (INVA) as of Q4 2015, down from 119 in Q3 2015.
- Funds reported $993M of Innoviva stock for Q4 2015, up 37% quarter-over-quarter.
- 14 funds opened new Innoviva positions in Q4 2015 and 35 closed out, a net change of -21 holders.
- The largest Innoviva buyer in Q4 2015 was PFM Health Sciences, an estimated $21.3M added.
- The largest Innoviva seller in Q4 2015 was Perry Capital, an estimated $18M sold.
Based on aggregated 13F filings for Q4 2015.